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De Novo Mutations of the Gene Encoding the Histone
Acetyltransferase KAT6B Cause Genitopatellar Syndrome
Michael A. Simpson,1,11 Charu Deshpande,2,11 Dimitra Dafou,1,11 Lisenka E.L.M. Vissers,3
Wesley J. Woollard,1 Susan E. Holder,4 Gabriele Gillessen-Kaesbach,5 Ronny Derks,3 Susan M. White,6
Ruthy Cohen-Snuijf,7 Sarina G. Kant,8 Lies H. Hoefsloot,3 Willie Reardon,9 Han G. Brunner,3
Ernie M.H.F. Bongers,3,12,* and Richard C. Trembath1,10,12,*
Genitopatellar syndrome (GPS) is a rare disorder in which patellar aplasia or hypoplasia is associated with external genital anomalies
and severe intellectual disability. Using an exome-sequencing approach, we identified de novo mutations of KAT6B in five individuals
with GPS; a single nonsense variant and three frameshift indels, including a 4 bp deletion observed in two cases. All identifiedmutations
are located within the terminal exon of the gene and are predicted to generate a truncated protein product lacking evolutionarily
conserved domains. KAT6B encodes a member of the MYST family of histone acetyltranferases. We demonstrate a reduced level of
both histone H3 and H4 acetylation in patient-derived cells suggesting that dysregulation of histone acetylation is a direct functional
consequence of GPS alleles. These findings define the genetic basis of GPS and illustrate the complex role of the regulation of histone
acetylation during development.Genitopatellar syndrome (GPS [MIM 606170]) is an
uncommon disorder in which patellar aplasia or hypo-
plasia is associated with external genital and renal anoma-
lies, congenital flexion deformities of the limbs, distinctive
facial features, corpus callosum agenesis, and severe intel-
lectual disability. This reported spectrum of ancillary
phenotypic features is consistent with a fundamental
defect in developmental processes.1–3 Congenital patellar
malformations comprise a clinically diverse and geneti-
cally heterogeneous group, including nail patella
syndrome (MIM 161200) and small patella syndrome
(MIM 147891), caused by mutations in the transcription
factors LMX1B and TBX4, respectively, and Meier-Gorlin
syndrome (ear, patella, short-stature syndrome [MIM
224690]) caused by mutations in five different prereplica-
tion complex genes.4–7 In contrast to the latter syndromes,
GPS is accompanied by severe intellectual disability and
cerebral anomalies. Recent studies have demonstrated
the effectiveness of exome sequencing in the elucidation
of the genetic basis of recessive and dominant monogenic
traits, including those caused by de novo mutations.8,9
To search for disease alleles in GPS we undertook whole
exome sequencing of six unrelated affected individuals. All
had characteristic clinical features of GPS (Figures 1A-1C
and Table 1). Ethical approval for this study was obtained
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formed by in-solution hybridization using the Sure Select
system (Agilent) followed bymassively parallel sequencing
(Illumina GAIIx [samples from individuals GPS-01, GPS-
02, GPS-03, and GPS-06] and Life Technologies SOLiD 4
[GPS-04 and GPS-05]). Over 4.7 gigabases of mappable
sequence data were generated for each subject, such that
>70% of the coding bases of the exome defined by the
GENCODE Project were represented by at least 20 reads
(Tables S1 and S2). Variant profiles were generated with
our respective in-house variant-calling pipelines (Table
S3).8,9 Reads generated on the Illumina GAIIx platform
were aligned to the reference human genome with the
Novoalign software package (Novocraft Technologies
Sdn Bhd). Duplicate reads, resulting from PCR clonality
or optical duplicates, and reads mapping to multiple
locations were excluded from downstream analysis.
Depth and breadth of sequence coverage was calculated
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Figure 1. Clinical and Genetic Findings of Individuals with Gen-
itopatellar Syndrome
(A) Facial features, including a coarse face, a broad bulbous nose,
downturned corners of the mouth, and micrognathia (individuals
GPS-02 [age 5 months], GPS-03 [age 3 months], and GPS-05 [age
5 months and 25 years, respectively]).
(B) Flexion contractures of the knees with skin dimples suggestive
of absent patella.
(C) Scrotal hypoplasia and cryptorchidism.
(D) Observed mutations with respect to the genomic organization
of KAT6B and the domain structure of KAT6B.were annotated with respect to genes and transcripts with
the Annovar tool.12 Reads generated on the Life Technolo-
gies SOLiD platform were mapped to the reference genome
with the SOLiD bioscope software (Life Technologies).
Single nucleotide variants were subsequently called by
the diBayes algorithm (Life Technologies). Small insertions
and deletions were detected using the SOLiD Small InDel
Tool (Life Technologies). All called variants and indels
were combined and annotated with custom analysis
scripts. As sibling recurrence of GPS has previously been
observed,1 we initially compared the six exome profiles
under a model of a rare autosomal-recessive inheritance,
but did not identify any gene harboring novel homozy-
gous or compound heterozygous protein-altering variants
in more than one individual (data not shown). Sub-
sequently, we interrogated these data under the assump-
tion that each of the causative alleles is dominant and
had arisen de novo; requiring at least one previously
unobserved heterozygous nonsynonymous or splice-site
substitution or a coding insertion or deletion in the same
gene in all six individuals. This process did not reveal
a single gene matching the criteria in all six individuals
(Table S4). However, evaluation of these data with a priorThe Americaexpectation of genetic heterogeneity highlighted KAT6B
(MIM 605880) as the only candidate gene harboring
previously unobserved heterozygous variants in five of
the six individuals (Table S4); a single nonsense variant
(c.3877A>T [p.Lys1293X]) and three frameshift indels,
including a 4 bp deletion observed in two cases
(c.3768_3771del [p.Lys1258GlyfsX13], c.3680_3695del
[p.Asp1227GlufsX11], and c.3773dup [p.Trp1259ValfsX12])
(Table 1).
The variants are all located within a 66 bp region of exon
18, the terminal exon, of KAT6B, which is located on
chromosome 10 and encodes an 8.5 kb transcript
(NM_012330.2). Each variant is predicted to lead to the
premature termination of the protein product that has
a high likelihood of functional impact (Figure 1D). None
of the observed mutations is present in dbSNP, has been
observed by the 1000 Genomes Project, or was detected
in 600 unrelated control exome profiles. The variants
were confirmed by Sanger sequencing in the respective
probands. Moreover, none of the mutations was present
in unaffected parental DNA from leukocytes, consistent
with the notion that the disease causing alleles have arisen
de novo. Of note, in the affected individual in whom
exome sequencing had not revealed any novel variation
(GPS-06), Sanger sequencing confirmed the wild-type
coding sequence of all 16 coding exons and their associ-
ated splice sites of KAT6B. Further to this, high-resolution
comparative genomic hybridization microarray analysis
did not identify any CNVs affecting KAT6B or any other
genomic abnormalities that could potentially explain the
phenotype (data not shown). This individual (GPS-06)
has very similar clinical features to the five individuals in
whom we identified mutations (Table 1). This case may
therefore represent a phenocopy of GPS, be explained
by locus heterogeneity in GPS or may arise through an
GPS allele comprising a non-coding or undetected coding
variant in KAT6B.
KAT6B (K(lysine) acetyltransferase 6B, previously known
as MORF, QKF, and MYST4) is a member of the MYST
family of proteins that are defined by a conserved acetyl-
transferase domain.13 Individual members of the MYST
family contain additional functional domains, in this
regard KAT6B shares structural similarity with KAT6A
(previously known as MOZ and MYST3). Both comprise
a conserved amino terminus containing an NEMM
domain and two consecutive PHD domains. The central
portion of these proteins is acidic and contains the MYST
domain. The carboxy terminus consists of a serine-rich
and methionine-rich domains that are unique to these
proteins. Interestingly, the four GPS alleles identified
in this study are all predicted to lead to truncation of
the KAT6B before translation of the serine-rich and
methionine-rich domains (Figure 1). To establish if the
mutant KAT6B alleles generate a stable transcript we
Sanger sequenced the KAT6B transcript from individual
GPS-02, heterozygous for the c.3768_3771del allele, which
confirmed the transcription of both mutant and wild-typen Journal of Human Genetics 90, 290–294, February 10, 2012 291
Table 1. Major Clinical and Genetic Findings in Six Individuals with Genitopatellar Syndrome
Individual
GPS-01a GPS-02 GPS-03 GPS-04 GPS-05 GPS-06a
KAT6B nucleotide alteration c.3680_3695del c.3768_3771del c.3768_3771del c.3877A>T c.3773dup –
KAT6B amino acid alternation p.Asp1227GlufsX11 p.Lys1258GlyfsX13 p.Lys1258GlyfsX13 p.Lys1293X p.Trp1259ValfsX12 –
Gender female female male male female male
Age at last examination 16 months 7 months 3 months 2 years 25 years 6 months
Genital Anomalies
Scrotal hypoplasia NA NA þ þ NA þ
Cryptorchidism NA NA þ þ NA –
Clitoral hypertrophy þ þ NA NA þ NA
Small clitoris – – NA NA – NA
Hypoplastic labia minora þ – NA NA þ NA
Patellar Malformations
Absent patellae þ (right) þ þ þ þ þ
Hypoplastic patellae þ (left) – – – – –
Lower Limb Flexion Deformities
Flexion contractures of the hips þ þ – – þ þ
Flexion contractures of the knees þ þ þ þ þ þ
Club foot þ þ þ þ – þ
Neurological
Aplasia of corpus callosum þ þ þ þ þ þ
Severe intellectual disability þ þ þ þ þ NA
Delayed motor milestones þ þ þ þ þ þ
Craniofacial Features
Microcephaly þ þ þ – þ þ
Coarse face þ þ þ þ þ þ
Broad/bulbous nose þ þ þ þ þ þ
Micrognathia þ þ þ – þ þ
Renal Anomalies
Hydronephrosis þ þ þ þ – þ
Multicystic kidneys – – – – – –
Other Anomalies
Pelvic anomaly – þ U þ þ –
Rib anomaly – – U – – –
Pulmonary hypoplasia U U U – – –
Heart defect þ (ASD, VSD, PDA) – þ (ASD) þ (PDA) – –
The following symbols and abbreviations are used: þ, feature present; –, feature absent, NA, not applicable; ASD, atrial septal defect; VSD, ventricular septal
defect; PDA, patent ductus arteriosus; U, unknown.
a Case reports from individuals GPS-01 and GPS-06 presented in Reardon2 and Brugha et al.,3 respectively.alleles (data not shown). We then used a quantitative
RT-PCR approach (Kapa Biosystems) performed on a
7900HT Fast Real-Time PCR System (Life Technologies)
to demonstrate that total abundance of KAT6B transcript
is equivalent to wild-type controls (Figure 2A). We inter-292 The American Journal of Human Genetics 90, 290–294, Februarypreted these findings to be in keeping with the established
notion that nonsense mutations in the terminal exon
of many genes have reduced capacity to activate the
process of nonsense mediated decay.14 Indeed, we were
able to detect a protein of the size of the predicted10, 2012
Figure 2. Evaluation of Mutant KAT6B Transcript Abundance
and Detection of Mutant KAT6B Protein
(A) Assessment of abundance of total KAT6B transcript in primary
skin fibroblasts from individual GPS-02 and the average of two
unrelated healthy controls (HDF). Error bars represent standard
error of the mean of three independent experiments.
(B) Detection of full length and truncated endogenous KAT6B in
individual GPS-02 heterozygous for the KAT6B alteration
p.Lys1258GlyfsX13.
Figure 3. Effect of KAT6B Mutation p.Lys1258GlyfsX13 on H3
and H4 Acetylation
Significant decrease of H3 and H4 acetylation in fibroblasts from
individual GPS-02 compared to the average of two HDF (*p <
0.05; t test). Error bars represent standard deviation of triplicate
measurements.truncated KAT6B in primary skin fibroblasts from indi-
vidual GPS-02 heterozygous for the mutation p.Lys1258-
GlyfsX13 using the ab58823 polyclonal rabbit antibody
(1:1,000) (Abcam) (Figure 2B). Taken together, these find-
ings suggest that GPS alleles generate a mature truncated
KAT6B protein.
KAT6B is the catalytic subunit of a tetrameric complex
that also comprises ING5, EAF6, and one of the members
of the bromodomain-PHD finger protein family BRPF.15
The formation of this complex stimulates the acetylation
of E-amino groups on lysine residues which has been prin-
cipally studied in the context of chromatin modeling. A
series of KAT6B deletion constructs have illustrated a direct
interaction between the BN domains of the BRPF family
with the MYST domain of KAT6B within the molecular
complex.15 The truncated forms of KAT6B observed in
this study are predicted to contain the full length MYST
domain and are therefore sufficient for complex forma-
tion. However, quantitative assessment of global H3/H4
acetylation of extracted histones demonstrated a signifi-
cant reduction in H3 and H4 acetylation in primary
skin fibroblasts from individual GPS-02, heterozygous
for the mutation Lys1258GlyfsX13, compared to primary
skin fibroblasts from healthy volunteers (EpiQuick Global
H3/H4 acetylation assay, performed according to the
manufacturer’s protocol) (Figure 3). This reduction
suggests that histone acetylation activity in affected indi-
viduals is compromised. GPS alleles are predicted to
encode a protein product that lacks the carboxy-terminal
serine-rich and methionine-rich domains. Taken together,
these data provide the basis to speculate that the absent
domains in the truncated proteins observed in GPS
may contribute to the regulation of the acetylation activity
of the tetrameric complex. Interestingly, the serine-rich
and methionine-rich domains have potent transcriptional
activation potential13 and have been demonstrated to
directly interact with the runt domain transcription
factor Runx2.16 The interaction negatively regulates the
transcriptional activation potential of these domains.
However, the effect of the interaction with RUNX2 on theThe Americaacetyltransferase activity of KAT6B has not yet been
investigated.
Mice homozygous for a hypomorphic genetrap allele
of Myst4 (the mouse ortholog of KAT6B) are known as
Querkopf mice and have expression levels of Myst4 that
are 5% of the levels in wild-type mice, which leads to
severe defects in the cerebral cortex and bone growth
development and exhibit facial dysmorphisms.17 In hu-
mans, a chromosomal breakpoint disrupting KAT6B has
recently been reported in a single individual with short
stature, ptosis, and low set ears that are reminiscent of
Noonan syndrome although no cardiac anomaly was re-
ported.18 The disruption of the gene in this individual
leads to a null allele resulting in 50% reduction in KAT6B
expression in the affected individual. The phenotypic
features of both the Querkopf mouse and the Noonan-
like phenotype have been ascribed to disrupted MAPK
signaling via a global dysregulation of histone acetylation
through haploinsufficiency of KAT6B.18 GPS is clearly
discrete from the phenotype that results from KAT6B
haploinsufficiency and likely results from distinct func-
tional consequences of the GPS alleles that lack the
serine-rich and methionine-rich domains. Of additional
note, Clayton-Smith and colleagues have very recently
identified mutations in KAT6B in a series of individuals
with the Say-Barber-Biesecker-Young-Simpson variant of
Ohdo syndrome, a multisystem developmental disorder
associated with severe intellectual disability and a charac-
teristic facial appearance.19 This form of Ohdo syndrome
is phenotypically distinct from GPS and further expands
the range of phenotypic expression associated with muta-
tions of this histone acetyltransferase.
In conclusion, we have used whole-exome sequencing
and identified de novo mutations of KAT6B as the molec-
ular genetic basis of GPS. Our data demonstrate that GPS
alleles generate a truncated protein lacking evolutionarily
conserved domains and functionally are associated with
disruption of histone acetylation. These findings illustrate
the critical and complex role of the regulation of histone
acetylation during development.n Journal of Human Genetics 90, 290–294, February 10, 2012 293
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